CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-27 | Musket David B Director | Option exercise · Stock Option (Right to Buy) | −15,455 | 0 | ||
| 2021-12-27 | Musket David B Director | Option exercise · Warrants (Right to Buy) | −20,391 | 0 | ||
| 2021-07-23 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-01-04 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +458,693 | 458,693 | ||
| 2021-01-04 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +72,066 | 72,066 | ||
| 2021-01-04 | Krasney Karen EVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +95,693 | 95,693 | ||
| 2021-01-04 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +71,388 | 71,388 | ||
| 2021-01-04 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +211,160 | 211,160 | ||
| 2021-01-04 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +71,951 | 71,951 | ||
| 2021-01-04 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +96,126 | 96,126 | ||
| 2021-01-04 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +95,693 | 95,693 | ||
| 2020-09-24 | Manzo Louis Director | Option exercise | +8,299 | $3.70 | $31K | 44,603 |
| 2020-09-24 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −8,299 | 0 | ||
| 2020-07-27 | Marban Linda CHIEF EXECUTIVE OFFICER | Option exercise | +41,497 | $3.70 | $154K | 62,367 |
| 2020-07-27 | Marban Linda CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −15,652 | $9.81 | $154K | 46,715 |
| 2020-07-27 | Marban Linda CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −41,497 | 0 | ||
| 2020-06-05 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +368,449 | 368,449 | ||
| 2020-06-05 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 | ||
| 2020-06-05 | Krasney Karen EVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +104,908 | 104,908 | ||
| 2020-06-05 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 |
Page 13 of 24 · 468 trades